[EN] HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER [FR] INHIBITEURS HÉTÉROCYCLIQUES D'EGFR DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DU CANCER
The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.